Publications of the KKNMS
Your search in the archive “Publications of the KKNMS” returned the following results:
-
The Glycosylation Site of Myelin Oligodendrocyte Glycoprotein Affects Autoantibody Recognition in a Large Proportion of Patients
Von Marti Fernandez et al, erschienen in „Front Immunol“ (Vol. 10, Juni 2019)
-
MCC950 blocks enhanced interleukin-1β production in patients with NLRP3 low penetrance variants
Von Schuh et al, erschienen in „Clin Immunol“ (Vol. 203, Juni 2019)
-
Optimal intereye difference thresholds by optical coherence tomography in multiple sclerosis: An international study
Von Nolan-Kenney et al, erschienen in „Ann Neurol“ (Vol. 85, Nr. 5, Mai 2019)
-
Drug-use patterns and severe adverse events with disease-modifying drugs in patients with multiple sclerosis: a cohort study based on German claims data
Von Simbrich et al, erschienen in „Neuropsychiatr Dis Treat“ (Vol. 15, Mai 2019)
-
A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis
Von International Multiple Sclerosis Genetics Consortium, erschienen in „Nat Commun“ (Vol. 10, Nr. 1, Mai 2019)
-
VLA-2 blockade in vivo by vatelizumab induces CD4+FoxP3+ regulatory T cells
Von Breuer et al, erschienen in „Int Immunol“ (Vol. 31, Nr. 6, Mai 2019)
-
Effect of HLA-DRB1 alleles and genetic variants on the development of neutralizing antibodies to interferon beta in the BEYOND and BENEFIT trials
Von Buck et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 4, April 2019)
-
Evidence for a white matter lesion size threshold to support the diagnosis of multiple sclerosis
Von Grahl et al, erschienen in „Mult Scler Relat Disord“ (Vol. 29, April 2019)
-
Association of smoking but not HLA-DRB1*15:01, APOE or body mass index with brain atrophy in early multiple sclerosis
Von Graetz et al, erschienen in „Mult Scler“ (Vol. 25, Nr. 5, April 2019)
-
Risks and risk management in modern multiple sclerosis immunotherapeutic treatment
Von Klotz et al, erschienen in „Ther Adv Neurol Disord“ (Vol. 12, April 2019)